RTP based Metabolon, Inc. is partnering with the European Group for the Study of Insulin Resistance (EGIR) to accelerate pre-diabetes diagnosis development. The collaboration with EGIR will help Metabolon accelerate the development of Quantose™ IR, its diagnostic test for better screening of pre-diabetic patients.
Metabalon Inc. is a CED member.